Therapeutic rAAVrh10 Mediated SOD1 Silencing in Adult SOD1(G93A) Mice and Nonhuman Primates

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease; survival in ALS is typically 3–5 years. No treatment extends patient survival by more than three months. Approximately 20% of familial ALS and 1–3% of sporadic ALS patients carry a mutation in the gene encoding superoxide dism...

Descripción completa

Detalles Bibliográficos
Autores principales: Borel, Florie, Gernoux, Gwladys, Cardozo, Brynn, Metterville, Jake P., Toro Cabreja, Gabriela C., Song, Lina, Su, Qin, Gao, Guang Ping, Elmallah, Mai K., Brown, Robert H., Mueller, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741242/
https://www.ncbi.nlm.nih.gov/pubmed/26710998
http://dx.doi.org/10.1089/hum.2015.122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741242/
https://www.ncbi.nlm.nih.gov/pubmed/26710998
http://dx.doi.org/10.1089/hum.2015.122

Ejemplares similares